The entire Apteeus team is delighted with this news. After months of fundraising, designing the trial in all its operational details, having the drug manufactured to pharmaceutical standards, developing the placebo and, finally, convincing people of the value and feasibility of the trial, the health authorities (ANSM) have just delivered to the Institut Pasteur de Lille, sponsor, a favorable opinion for the Therapide trial which will therefore begin in the coming days.
